- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Paediatric Crohn’s disease is an inflammatory bowel disease characterized by severe, chronic inflammation of the intestinal wall or part of the gastrointestinal tract (group of organs connected by tubes that run from the mouth to the anus). Once considered a rare condition in the pediatric population, it is now recognized as one of the most important chronic diseases affecting children and adolescents.
Showing all 8 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hulio® |
50 mg/mL |
– |
2 mg |
-80°C |
02/2023 |
265,50 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Imraldi® |
50 mg/mL |
– |
2 mg |
-80 °C |
10/2023 |
295,00 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
11/2019 |
178,20 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
08/2019 |
178,20 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
02/2020 |
178,20 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
03/2021 |
178,20 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
12/2020 |
178,20 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
yes |
2 mg |
-80°C |
11/2024 |
208,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin